NCT06231277 2024-01-30
BH002-â… -101
Zhuhai Beihai Biotech Co., Ltd
Phase 1 Completed
Clinical Trials
18 trialsNCT04179071 2020-07-07
A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine
AstraZeneca
Phase 1 Completed
NCT02264418 2020-01-18
KIDES-203
Orion Corporation, Orion Pharma
Phase 1 Completed
NCT03333824 2019-03-25
Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer
AstraZeneca
Phase 1 Completed
NCT03315091 2018-04-30
Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT01998607 2018-01-09
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
Amgen
Completed
NCT00732420 2017-11-13
Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00136578 2017-09-25
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00742131 2017-07-31
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00743067 2017-07-26
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00742261 2017-07-07
A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT02215850 2016-05-17
Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours
Welichem Biotech Inc.
Phase 1 Completed
NCT01209091 2016-02-03
Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden
GlaxoSmithKline
Completed
NCT02056392 2015-11-09
To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers
AstraZeneca
Phase 1 Completed
NCT01931761 2015-06-30
Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers
AstraZeneca
Phase 1 Completed
NCT02093728 2015-06-30
To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers
AstraZeneca
Phase 1 Completed
NCT01974349 2014-08-13
To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers
AstraZeneca
Phase 1 Completed
NCT02046850 2014-04-29
To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers
AstraZeneca
Phase 1 Completed